Blood flow restriction training before platelet-rich plasma preparation induces a significant reduction in its interleukin-6 levels: A pilot randomised controlled trial

在制备富血小板血浆之前进行血流限制训练可显著降低其白细胞介素-6水平:一项初步随机对照试验

阅读:1

Abstract

PURPOSE: To assess platelet-rich plasma (PRP) changes in platelet and leucocyte count, insulin-like growth factor (IGF-1) and interleukin 6 (IL-6) concentration after bilateral low-load knee extensions with blood flow restriction (BFR). METHODS: A randomised controlled trial involving two groups was conducted. The intervention group underwent low-load bilateral knee extensions with BFR, while the control group without BFR. Inclusion criteria were (1) male individuals, (2) between 18 and 40 years, (3) with Tegner activity level ≥5 and (4) no musculoskeletal conditions that would interfere with exercise. The participant performed a standard protocol of 30-15-15-15 repetitions of consecutive sets with 30-s rest intervals at 80% of limb occlusive pressure and a 15-lb load. PRP platelet and leucocyte count, IGF-1 and IL-6 concentration measurements (via flow cytometry, chemiluminescence testing and immunochromatography, respectively) were conducted before exercise and 10, 20 and 30 min after the intervention (T1, T2, T3 and T4, respectively). RESULTS: A total of 24 participants were enrolled and allocated into two groups. The exercise bout in the BFR group resulted in higher platelet concentration and dose at T2 and T3, reaching a mean 9.9% maximum concentration increase and a mean 15.6% maximum dose increase at T2 (p = 0.07). Similarly, leucocyte concentrations and dose presented a steep decrease at T2, representing a 17.8% and 16.8% decrease, respectively. Moreover, a peak increase in IGF-1 concentration of 4.1% above baseline was observed at T3. IL-6 concentrations were significantly lower at all time points in the BFR group (˂1 pg/mL, p = 0.01). CONCLUSION: Low-load bilateral knee extensions with BFR induced a significant reduction of IL-6 concentration in PRP, which holds potential to tailor treatment for specific musculoskeletal injuries. LEVEL OF EVIDENCE: Level I.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。